|
1
|
Thompson LD: Osteosarcoma. Ear Nose Throat
J. 92:288–290. 2013.PubMed/NCBI
|
|
2
|
Zhang J, Yu XH, Yan YG, Wang C and Wang
WJ: PI3K/Akt signaling in osteosarcoma. Clin Chim Acta.
444:182–192. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chang Z, Huo L, Li K, Wu Y and Hu Z:
Blocked autophagy by miR-101 enhances osteosarcoma cell
chemosensitivity in vitro. Scientific World Journal.
2014:7947562014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhou Y, Huang Z, Wu S, Zang X, Liu M and
Shi J: miR-33a is up-regulated in chemoresistant osteosarcoma and
promotes osteosarcoma cell resistance to cisplatin by
down-regulating TWIST. J Exp Clin Cancer Res. 33:122014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer.
94:776–780. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Croce CM and Calin GA: miRNAs, cancer, and
stem cell division. Cell. 122:6–7. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu L, Wang F, Xu XF, Mo WH, Xia YJ, Wan R,
Wang XP and Guo CY: Down-regulation of miR-212 expression by DNA
hypermethylation in human gastric cancer cells. Med Oncol.
28:(Suppl 1). S189–S196. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Park JK, Henry JC, Jiang J, Esau C, Gusev
Y, Lerner MR, Postier RG, Brackett DJ and Schmittgen TD: miR-132
and miR-212 are increased in pancreatic cancer and target the
retinoblastoma tumor suppressor. Biochem Biophys Res Commun.
406:518–523. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Luo XJ, Tang DG, Gao TL, Zhang YL, Wang M,
Quan ZX and Chen J: MicroRNA-212 inhibits osteosarcoma cells
proliferation and invasion by down-regulation of Sox4. Cell Physiol
Biochem. 34:2180–2188. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiang L, He A, Zhang Q and Tao C: miR-126
inhibits cell growth, invasion, and migration of osteosarcoma cells
by downregulating ADAM-9. Tumour Biol. 35:12645–12654. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Geng S, Zhang X, Chen J, Liu X, Zhang H,
Xu X, Ma Y, Li B, Zhang Y, Bi Z and Yang C: The tumor suppressor
role of miR-124 in osteosarcoma. PLoS One. 9:e915662014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fan L, Wu Q, Xing X, Wei Y and Shao Z:
MicroRNA-145 targets vascular endothelial growth factor and
inhibits invasion and metastasis of osteosarcoma cells. Acta
Biochim Biophys Sin (Shanghai). 44:407–414. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wada R, Akiyama Y, Hashimoto Y, Fukamachi
H and Yuasa Y: miR-212 is downregulated and suppresses
methyl-CpG-binding protein MeCP2 in human gastric cancer. Int J
Cancer. 127:1106–1114. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao JL, Zhang L, Guo X, Wang JH, Zhou W,
Liu M, Li X and Tang H: miR-212/132 downregulates SMAD2 expression
to suppress the G1/S phase transition of the cell cycle and the
epithelial to mesenchymal transition in cervical cancer cells.
IUBMB Life. 67:380–394. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wei LQ, Liang HT, Qin DC, Jin HF, Zhao Y
and She MC: MiR-212 exerts suppressive effect on SKOV3 ovarian
cancer cells through targeting HBEGF. Tumour Biol. 35:12427–12434.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Y, Zhang D, Chen C, Ruan Z, Li Y and
Huang Y: MicroRNA-212 displays tumor-promoting properties in
non-small cell lung cancer cells and targets the hedgehog pathway
receptor PTCH1. Mol Biol Cell. 23:1423–1434. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Robinson JL and Carroll JS: FoxA1 is a key
mediator of hormonal response in breast and prostate cancer. Front
Endocrinol (Lausanne). 3:682012.PubMed/NCBI
|
|
19
|
Guo W, Keener AL, Jing Y, Cai L, Ai J,
Zhang J, Fisher AL, Fu G and Wang Z: FOXA1 modulates EAF2
regulation of AR transcriptional activity, cell proliferation, and
migration in prostate cancer cells. Prostate. 75:976–987. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qiu M, Bao W, Wang J, Yang T, He X, Liao Y
and Wan X: FOXA1 promotes tumor cell proliferation through AR
involving the Notch pathway in endometrial cancer. BMC Cancer.
14:782014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zheng L, Qian B, Tian D, Tang T, Wan S,
Wang L, Zhu L and Geng X: FOXA1 positively regulates gene
expression by changing gene methylation status in human breast
cancer MCF-7 cells. Int J Clin Exp Pathol. 8:96–106.
2015.PubMed/NCBI
|
|
22
|
Dou C, Wang Y, Li C, Liu Z, Jia Y, Li Q,
Yang W, Yao Y, Liu Q and Tu K: MicroRNA-212 suppresses tumor growth
of human hepatocellular carcinoma by targeting FOXA1. Oncotarget.
6:13216–13228. 2015. View Article : Google Scholar : PubMed/NCBI
|
